Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis

    Recruiting

    1 1 1 1
    Bulgaria Hungary Italy Poland Spain Sweden
  • Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark France +7
  • Study on Baricitinib for Patients with Relapsing or Naïve Dermatomyositis

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Upadacitinib for Patients with Idiopathic Inflammatory Myopathies After Stopping IVIG

    Recruiting

    1 1
    Investigated drugs:
    Austria
  • Study on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis

    Recruiting

    1 1
    Investigated drugs:
    Germany
  • Study on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Bulgaria France Germany Hungary Italy +4
  • Study on Filgotinib for Patients with Refractory Behcet’s Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet’s Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • A study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe

    Not recruiting

    1 1
    Belgium Bulgaria Czechia Germany Hungary Italy +6
  • Study on Baricitinib for Treating New-Onset Juvenile Dermatomyositis in Children

    Not recruiting

    1 1 1
    Investigated drugs:
    France